EDGAR Filing Documents for 0000950123-09-063958

Form 8-K - Current report:

SEC Accession No. 0000950123-09-063958

Filing Date

2009-11-18

Accepted

2009-11-18 16:40:42

Documents

Period of Report

2009-11-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	w76386e8vk.htm	8-K	20605
2	EX-4.1	w76386exv4w1.htm	EX-4.1	67574
3	EX-10.1	w76386exv10w1.htm	EX-10.1	164364
4	EX-99.1	w76386exv99w1.htm	EX-99.1	6379
5	GRAPHIC	w76386w7638601.gif	GRAPHIC	1496
6	GRAPHIC	w76386w7638602.gif	GRAPHIC	4518
	Complete submission text file	0000950123-09-063958.txt		269545

Mailing Address 10 FORGE PARKWAY FRANKLIN MA 02038

Business Address 10 FORGE PARKWAY FRANKLIN MA 02038 508 553-8850

Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)